Figure 2
From: Rationale for short course primaquine in Africa to interrupt malaria transmission
The effect of annual MDA with primaquine in addition to primaquine and ACT treatment of clinical cases in a low transmission setting. In a seasonal, low transmission setting, giving ACT+ primaquine to clinical cases plus an annual MDA with ACT plus primaquine could reduce malaria levels close to elimination if repeated for a number of years; however the model does notallow for immigration of malaria cases. With the kind permissionof Lucy Okell, Jamie Griffin & Azra Ghani. For further details,see reference [40].